Cannabis Improves Stuttering: Case Report and Interview with the Patient.
Natalia SzejkoCarolin FremerFranziska BaackeMartin PtokKirsten R Muller-VahlPublished in: Cannabis and cannabinoid research (2021)
Introduction: Speech dysfluency, often referred to as stuttering, is a frequent speech disorder encountered in about 5% of children. Although in the majority of people affected, symptoms improve in adulthood, in some patients, stuttering persists and significantly impairs everyday functioning and quality of life. Treatment for stuttering includes speech therapy, cognitive behavioral therapy, and relaxation techniques. However, a substantial number of patients do not benefit sufficiently from these treatment strategies or are even treatment resistant. Methods: We present the case of a 20-year-old male with treatment-resistant stuttering, who markedly improved after treatment with medicinal cannabis. Results: Besides improved speech fluency as assessed by several phoniatric tests, we observed remission of (social) anxiety, improved mood, and reduced stress, resulting in an overall improvement of quality of life after cannabis therapy. The patient, in addition, reported improved attention, concentration, and sleep, increased self-confidence, and better social life. No side effects occurred. Over a time period of more than a year, treatment was equally effective. In an interview, the patient describes his personal view and the influence of cannabis-based treatment on his life. Conclusions: Medicinal cannabis could be effective in treatment of refractory stuttering, but these preliminary data have to be confirmed in controlled studies.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- case report
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- stem cells
- sleep quality
- systemic lupus erythematosus
- physical activity
- rheumatoid arthritis
- machine learning
- depressive symptoms
- patient reported outcomes
- artificial intelligence
- electronic health record
- disease activity
- obsessive compulsive disorder
- patient reported
- deep brain stimulation
- stress induced
- drug discovery